rs3749099

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022336.4(EDAR):​c.870C>T​(p.Pro290Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0071 in 1,613,616 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 7 hom., cov: 31)
Exomes 𝑓: 0.0072 ( 82 hom. )

Consequence

EDAR
NM_022336.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.63

Publications

4 publications found
Variant links:
Genes affected
EDAR (HGNC:2895): (ectodysplasin A receptor) This gene encodes a member of the tumor necrosis factor receptor family. The encoded transmembrane protein is a receptor for the soluble ligand ectodysplasin A, and can activate the nuclear factor-kappaB, JNK, and caspase-independent cell death pathways. It is required for the development of hair, teeth, and other ectodermal derivatives. Mutations in this gene result in autosomal dominant and recessive forms of hypohidrotic ectodermal dysplasia. [provided by RefSeq, Jul 2008]
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 2-108907953-G-A is Benign according to our data. Variant chr2-108907953-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.63 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00573 (872/152210) while in subpopulation SAS AF = 0.0226 (109/4816). AF 95% confidence interval is 0.0192. There are 7 homozygotes in GnomAd4. There are 449 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022336.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EDAR
NM_022336.4
MANE Select
c.870C>Tp.Pro290Pro
synonymous
Exon 10 of 12NP_071731.1Q9UNE0-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EDAR
ENST00000258443.7
TSL:1 MANE Select
c.870C>Tp.Pro290Pro
synonymous
Exon 10 of 12ENSP00000258443.2Q9UNE0-1
EDAR
ENST00000376651.1
TSL:2
c.966C>Tp.Pro322Pro
synonymous
Exon 9 of 11ENSP00000365839.1Q9UNE0-2
EDAR
ENST00000409271.5
TSL:2
c.966C>Tp.Pro322Pro
synonymous
Exon 10 of 12ENSP00000386371.1Q9UNE0-2

Frequencies

GnomAD3 genomes
AF:
0.00573
AC:
871
AN:
152092
Hom.:
7
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00511
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0165
Gnomad SAS
AF:
0.0224
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00557
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00795
AC:
1979
AN:
248816
AF XY:
0.00830
show subpopulations
Gnomad AFR exome
AF:
0.00525
Gnomad AMR exome
AF:
0.00486
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.0240
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00539
Gnomad OTH exome
AF:
0.00785
GnomAD4 exome
AF:
0.00724
AC:
10581
AN:
1461406
Hom.:
82
Cov.:
31
AF XY:
0.00758
AC XY:
5508
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.00532
AC:
178
AN:
33480
American (AMR)
AF:
0.00501
AC:
224
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26136
East Asian (EAS)
AF:
0.0322
AC:
1277
AN:
39698
South Asian (SAS)
AF:
0.0196
AC:
1689
AN:
86252
European-Finnish (FIN)
AF:
0.000680
AC:
36
AN:
52980
Middle Eastern (MID)
AF:
0.00624
AC:
36
AN:
5768
European-Non Finnish (NFE)
AF:
0.00601
AC:
6681
AN:
1111978
Other (OTH)
AF:
0.00699
AC:
422
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
538
1076
1615
2153
2691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00573
AC:
872
AN:
152210
Hom.:
7
Cov.:
31
AF XY:
0.00603
AC XY:
449
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.00428
AC:
178
AN:
41544
American (AMR)
AF:
0.00510
AC:
78
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.0165
AC:
85
AN:
5154
South Asian (SAS)
AF:
0.0226
AC:
109
AN:
4816
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10610
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00557
AC:
379
AN:
68012
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00530
Hom.:
3
Bravo
AF:
0.00579
Asia WGS
AF:
0.0250
AC:
88
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;C3888065:Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant (1)
-
-
1
HAIR MORPHOLOGY 1;C3887494:Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive;C3888065:Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant (1)
-
-
1
Hypohidrotic ectodermal dysplasia (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
1.6
DANN
Benign
0.75
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3749099; hg19: chr2-109524409; COSMIC: COSV51503030; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.